Clincosm LogoSign in Get a demo

HIV-1-infection

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Abacavir and Lamivudine Anabolites

Completed
  • HIV-1-infection
  • Blood collection
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 5, 2023

HIV-1-infection, Adiposity, Insulin Resistance Trial in Brazil, United States (Semaglutide)

Active, not recruiting
  • HIV-1-infection
  • +4 more
  • Birmingham, Alabama
  • +7 more
Dec 7, 2022

HIV-1-infection Trial in Worldwide (B/F/TAF, F/TAF, DTG)

Completed
Has Results
  • HIV-1-infection
  • Phoenix, Arizona
  • +93 more
Dec 14, 2021

INSTI-associated Weight Gain: a Focus on Energy Balance

Recruiting
  • HIV-1-infection
  • Weight Gain
  • Aurora, Colorado
  • +1 more
Jun 2, 2021

HIV/AIDS, HIV-1-infection, Osteopenia Trial in United States (Dolutegravir (DTG) 50MG/lamivudine (3TC) 300MG FIXED DOSE

Withdrawn
  • HIV/AIDS
  • +2 more
  • Dolutegravir (DTG) 50MG/lamivudine (3TC) 300MG FIXED DOSE COMBINATION (FDC)
  • Current tenofovir alafenamide (TAF)-containing ART regimen
  • Birmingham, Alabama
  • +9 more
Mar 10, 2021

HIV-1 Reservoir in Central Nervous System of

Completed
  • HIV-1-infection
    • Los Angeles, California
    • +11 more
    Jul 7, 2020